John Tisdale

John Tisdale received his medical degree from the Medical University of South Carolina in
Charleston after obtaining his B.A. in Chemistry from the College of Charleston. He completed
an internal medicine and chief residency at Vanderbilt University Medical Center in Nashville
and then trained in hematology in the Hematology Branch, National Heart, Lung and Blood
Institute (NHLBI), where he served as a postdoctoral fellow. He joined the Molecular and
Clinical Hematology Branch of NHLBI in 1998 and is now the Chief of the Cellular and Molecular
Therapeutics Branch. In 2020 the College of Charleston recognized Dr. Tisdale as one of their
Top 25 History makers in honor of the schools 250-year anniversary and was Samuel J. Heyman
Service to America Medal finalist. He was recently elected to the American Society for Clinical
Investigation and is a member of the American Society of Hematology. Dr. Tisdale’s research
and clinical work center on sickle cell disease. His group focuses on developing curative
strategies for sickle cell disease through transplantation of allogeneic or genetically modified
autologous bone marrow stem cells. He has published over 200 first- and co-author